hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06369636, orgStudyIdInfo id: myucesu, briefTitle: Comparison of El-Ganzouri Risk Index and Airway Ultrasonographic Evaluation in Thyroid Surgery, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-06-01, primaryCompletionDateStruct date: 2023-10-31, completionDateStruct date: 2024-01-28, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Ankara City Hospital Bilkent, class: OTHER, descriptionModule briefSummary: The primary purpose of this prospective observational study was to compare these tests used to predict difficult intubation in patients undergoing thyroid surgery. Secondarily; By comparing these tests, we aim to find the test that best predicts difficult intubation and to determine the incidence of difficult intubation in patients who will undergo thyroid surgery., conditionsModule conditions: Thyroid Surgery, conditions: Difficult Intubation, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 120, type: ACTUAL, armsInterventionsModule interventions name: Thyroid Surgery, outcomesModule primaryOutcomes measure: Compare EGRI and airway ultrasonographic parameters, secondaryOutcomes measure: Find which is the best test predicts difficult intubation, secondaryOutcomes measure: Finding the incidence of difficult intubation in thyroid surgery, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ankara Bilkent City Hospital, city: Ankara, state: Çankaya, zip: 06800, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06369623, orgStudyIdInfo id: IRB2023-00466, briefTitle: Monetary Incentive Delay Task for Probing Reward-related Neural Processes, acronym: MID, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-06, primaryCompletionDateStruct date: 2028-11-30, completionDateStruct date: 2028-11-30, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Stony Brook University, class: OTHER, descriptionModule briefSummary: 150 males and 150 females ages 14-17 years-old will be enrolled in an observational, longitudinal study. There are three planned in-person visits: a baseline assessment, an 18-month follow-up, and a 36-month follow-up. The in-person visits will include assessment of substance use and other individual differences (e.g., reward function, psychiatric history), neuromelanin-sensitive MRI, as well as functional brain activation collected while the participant is at rest (resting-state fMRI) and while the participant completes a Monetary Incentive Delay task. Subjects will also be asked to complete past 90-day substance use assessments remotely every 90 days for 36 months., conditionsModule conditions: Adolescent Development, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 300, type: ESTIMATED, armsInterventionsModule interventions name: Monetary Incentive Delay Task, outcomesModule primaryOutcomes measure: Functional Brain Activation from Monetary Incentive Delay Task, eligibilityModule sex: ALL, minimumAge: 14 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule locations facility: Stony Brook Medicine, status: RECRUITING, city: Stony Brook, state: New York, zip: 11794, country: United States, contacts name: Greg Perlman, PhD, role: CONTACT, phone: 631-638-1922, email: greg.perlman@stonybrookmedicine.edu, contacts name: Roman Kotov, PhD, role: CONTACT, contacts name: Greg Perlman, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.92565, lon: -73.14094, hasResults: False
protocolSection identificationModule nctId: NCT06369610, orgStudyIdInfo id: GMROA2256, secondaryIdInfos id: NCI-2024-03020, type: REGISTRY, domain: CTRP (Clinical Trial Reporting Program), secondaryIdInfos id: 22-012591, type: OTHER, domain: Mayo Clinic Institutional Review Board, secondaryIdInfos id: GMROA2256, type: OTHER, domain: Mayo Clinic in Arizona, briefTitle: Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-22, primaryCompletionDateStruct date: 2027-04-22, completionDateStruct date: 2027-04-22, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-24, sponsorCollaboratorsModule leadSponsor name: Mayo Clinic, class: OTHER, descriptionModule briefSummary: This phase II trial tests how well risk based de-escalated hormone therapy (i.e., fewer treatments) with radiation works in treating patients with prostate cancer. Androgen deprivation therapy (ADT), such as gonadotropin-releasing hormone analogs (LHRH) and abiraterone acetate (Zytiga), lower the amount of the male hormone, testosterone, made by the body. This may help kill or stop the growth of tumor cells that need testosterone to grow. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Research has shown that long-term ADT is beneficial for patients with high-risk prostate cancer. However, there are few studies that determine ADT treatment based on risk factors. Giving risk based de-escalated ADT with radiation therapy may be as effective as giving more ADT in treating high-risk prostate cancer., conditionsModule conditions: Oligometastatic Prostate Carcinoma, conditions: Prostate Adenocarcinoma, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 64, type: ESTIMATED, armsInterventionsModule interventions name: Abiraterone Acetate, interventions name: Biospecimen Collection, interventions name: Computed Tomography, interventions name: Gonadotropin-releasing Hormone Analog, interventions name: Magnetic Resonance Imaging, interventions name: Positron Emission Tomography, interventions name: Questionnaire Administration, interventions name: Radiation Therapy, outcomesModule primaryOutcomes measure: Hormonal domain scores, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Mayo Clinic in Arizona, status: RECRUITING, city: Scottsdale, state: Arizona, zip: 85259, country: United States, contacts name: Clinical Trials Referral Office, role: CONTACT, phone: 855-776-0015, email: mayocliniccancerstudies@mayo.edu, contacts name: Carlos E. Vargas, M.D., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 33.50921, lon: -111.89903, hasResults: False
protocolSection identificationModule nctId: NCT06369597, orgStudyIdInfo id: Robot2024, briefTitle: A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-15, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-03-31, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Sun Yat-sen University, class: OTHER, descriptionModule briefSummary: This is a randomized controlled trial that will be preceded by a safety trial focusing on the safety and efficacy of robotic telesurgery. The hypothesis is that robotic telesurgery has a non-inferior primary endpoint event rate to local laparoscopic surgery., conditionsModule conditions: Liver Cancer, conditions: Renal Cancer, conditions: Rectal Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 177, type: ESTIMATED, armsInterventionsModule interventions name: Robotic telesurgery, interventions name: Laparoscopic surgery, outcomesModule primaryOutcomes measure: Surgical complication, secondaryOutcomes measure: Surgical time (min), secondaryOutcomes measure: Intraoperative blood loss (mL), secondaryOutcomes measure: Postoperative hospitalization days, secondaryOutcomes measure: Physician satisfaction, secondaryOutcomes measure: Remote metrics, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: First Affiliated Hospital, Sun Yat-Sen University, city: Guangzhou, state: Guangdong, zip: 510080, country: China, contacts name: Kuang Ming, PhD, role: CONTACT, phone: 008687755766, phoneExt: 8576, email: kuangm@mail.sysu.edu.cn, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06369571, orgStudyIdInfo id: IRB00439268, briefTitle: Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07, primaryCompletionDateStruct date: 2027-01, completionDateStruct date: 2027-12, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Johns Hopkins University, class: OTHER, collaborators name: American Heart Association, descriptionModule briefSummary: Ketogenic diet therapies (KDTs) emphasize high fat and very low carbohydrate intake and help to control seizures in adults who fail to respond to medications. However, KDT use can lead to increased cholesterol levels in some adults with epilepsy (AWE). Treatments that can reverse elevations in cholesterol observed with long-term KDT use without compromising diet adherence and seizure control are needed. The proposed study will explore the feasibility and safety of diet modification and statin use to lower cholesterol in this population. Study findings will help guide doctors utilizing KDTs in adults with epilepsy on how to approach managing elevations in cholesterol., conditionsModule conditions: Epilepsy, conditions: Dyslipidemia, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 22, type: ESTIMATED, armsInterventionsModule interventions name: Atorvastatin 10mg, interventions name: Modification of dietary fat composition, outcomesModule primaryOutcomes measure: Diet adherence as assessed by 3 day food records, primaryOutcomes measure: Statin Adherence, primaryOutcomes measure: LDL Change, primaryOutcomes measure: Change in weekly seizure frequency, primaryOutcomes measure: Seizure severity questionnaire score, secondaryOutcomes measure: Frequency of adverse events, secondaryOutcomes measure: Blood ketone change, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06369558, orgStudyIdInfo id: BiruniUniversi, briefTitle: Plyometric Exercise Training in Athletes With Chronic Low Back Pain, statusModule overallStatus: COMPLETED, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-04-04, completionDateStruct date: 2024-04-04, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Ugur Cavlak, class: OTHER, collaborators name: Biruni University, descriptionModule briefSummary: The aim of this study is to examine the effectiveness of plyometric exercise training in the athletes with chronic low back pain. 32 professional volunteer athletes participated in the study., conditionsModule conditions: Low Back Pain, Mechanical, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized controlled trial, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 32, type: ACTUAL, armsInterventionsModule interventions name: PLYOMETRIC TRAINING, interventions name: CLASSIC PHYSIOTHERAPY PROGRAM, outcomesModule primaryOutcomes measure: VISUAL ANALOG SCALE, primaryOutcomes measure: OSWESTRY DISABILITY INDEX, primaryOutcomes measure: SIT AND REACH TEST, primaryOutcomes measure: VERTICAL JUMP TEST, primaryOutcomes measure: FLAMINGO BALANCE TEST, primaryOutcomes measure: SHUTTLE RUNNİNG (20 MİN.), primaryOutcomes measure: MANUAL MUSCLE STRENGTH TEST, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 25 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Health Sciences in Biruni University, city: İ̇stanbul, state: Zeytinburnu, zip: 34010, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06369545, orgStudyIdInfo id: BiruniUniver, briefTitle: Chronic Pelvic Pain Syndrome in Males, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2024-04-04, completionDateStruct date: 2024-08-15, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Biruni University, class: OTHER, descriptionModule briefSummary: The aim of this study is to evaluate the effectiveness of ESWT (Extracorporeal Shock Wave Therapy) and TENS (Transcutaneous Electrical Nerve Stimulation) in individuals diagnosed with chronic pelvic pain syndrome and treated with medication. The study was organized as a randomized controlled trial. The sample size is 30 patients suffering from chronic pelvic pain syndrome., conditionsModule conditions: Pelvic Pain Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized Controled Trial, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 38, type: ESTIMATED, armsInterventionsModule interventions name: EXERCISE, interventions name: TENS, interventions name: ESWT, outcomesModule primaryOutcomes measure: VISUAL ANALOUGE SCALE, primaryOutcomes measure: National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), primaryOutcomes measure: ALGOMETER, secondaryOutcomes measure: Hospital Anxiety and Depression Scale- HAD, secondaryOutcomes measure: Nottingham Health Profile-NHP, secondaryOutcomes measure: Digital Muscle Testing, secondaryOutcomes measure: Flexibility Measurements, secondaryOutcomes measure: ROM Assessments, secondaryOutcomes measure: Lasegue Test, eligibilityModule sex: MALE, minimumAge: 20 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of Health Sciences in Biruni University, status: RECRUITING, city: İ̇stanbul, state: Zeytinburnu, zip: 34010, country: Turkey, contacts name: UGUR CAVLAK, Prof., PhD., role: CONTACT, phone: 00905324519644, email: ucavlak@biruni.edu.tr, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06369532, orgStudyIdInfo id: ONZ-2023-0460, briefTitle: Combination of Neurostimulation and Psychotherapy to Stop Worrying, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-06, primaryCompletionDateStruct date: 2026-02-20, completionDateStruct date: 2027-02-20, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: University Hospital, Ghent, class: OTHER, descriptionModule briefSummary: This study aims to investigate whether the combination of transcranial Direct Current Stimulation (tDCS) and cognitive-behavioral therapy (CBT) is more effective for treating repetitive negative thinking (RNT) in patients with the symptom of high rumination. High ruminators will be included (Group1, active tDCS-CBT group; Group2, sham tDCS-CBT group). All patients will receive active or sham tDCS., conditionsModule conditions: Active tDCS, conditions: Sham tDCS, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, maskingDescription: Participants will be allocated into two groups randomly (using a code). The psychotherapist, the study managers and the patients will not be aware of treatment allocation., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 85, type: ESTIMATED, armsInterventionsModule interventions name: Active tDCS, interventions name: Sham tDCS, outcomesModule primaryOutcomes measure: the therapeutic effect of the combination therapy for repetitive negative thinking, primaryOutcomes measure: the consolidation effect of tDCS on CBT, secondaryOutcomes measure: Change of neuroimaging data, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hospital Ghent, status: RECRUITING, city: Ghent, state: East-Flanders, zip: 9000, country: Belgium, contacts name: Chris Baeken, Prof., role: CONTACT, contacts name: Josefien Dedoncker, M.Sc., role: CONTACT, geoPoint lat: 51.05, lon: 3.71667, hasResults: False
protocolSection identificationModule nctId: NCT06369519, orgStudyIdInfo id: 2023#17-23, briefTitle: Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma, statusModule overallStatus: COMPLETED, startDateStruct date: 2000-01-01, primaryCompletionDateStruct date: 2020-12-31, completionDateStruct date: 2020-12-31, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Peking University First Hospital, class: OTHER, descriptionModule briefSummary: Sporadic bilateral renal cell carcinoma (BRCC) is a rare situation of RCC. The treatment for BRCC is controversial and there is a lack of authoritative guidelines about the management of BRCC. The goal of this cohort study is to identify prognostic factors, construct predictive nomograms, and optimize management for sporadic BRCC patients. The main questions it aims to answer are:What are the factors influencing the prognosis of BRCC patients? What's the appropriate treatment for BRCC patients?Researchers will analysis the prognostic factors and compare the prognosis of BRCC patients receiving different treatments., conditionsModule conditions: Kidney Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 3677, type: ACTUAL, armsInterventionsModule interventions name: Surgery treatment or local tumor destruction., outcomesModule primaryOutcomes measure: Overall survival (OS), secondaryOutcomes measure: Cancer-specific survival (CSS), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Peking University First Hospital, city: Beijing, state: Beijing, zip: 100034, country: China, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06369506, orgStudyIdInfo id: PYO.DIS.1904 Protocol ID:4467, briefTitle: Evaluation of Gingival Thickness Measurement at Different Anatomical Landmarks, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-10, primaryCompletionDateStruct date: 2023-08-05, completionDateStruct date: 2023-12-17, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Ondokuz Mayıs University, class: OTHER, descriptionModule briefSummary: In this study, the point at which gingival thickness (GT) should be measured was investigated. Measurements were made from three different points. It was classified as thin and thick in two ways, according to the average of these three different points and the point corresponding to the base of the gingival groove, which is frequently used in the literature. And these two classifications were compared., conditionsModule conditions: Gingival Thickness, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants were divided into two different classifications: "thin" and "thick". The first classification was made by measuring the GT of the point corresponding to the base of the gingival sulcus. GT was defined as thin if ≤1 mm, and thick if \>1 mm. In the second classification, GT was measured from three different points. And according to the average GT of three points, they were equally classified as "thin" and "thick"., primaryPurpose: SCREENING, maskingInfo masking: NONE, enrollmentInfo count: 50, type: ACTUAL, armsInterventionsModule interventions name: GTmeasurement, outcomesModule primaryOutcomes measure: Examining the sensitivities and sensitivities of two different gingival phenotype classifications based on three-point average GT measurement and single-point measurement using Receiver Operating Characteristic Analysis (ROC)., primaryOutcomes measure: Examining the agreement of GT measurements at three different points in 50 patients, 1195 teeth, using Kappa analysis., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ondokuz Mayis University Faculty of Dentistry Department of Periodontology, city: Samsun, zip: 55000, country: Turkey, geoPoint lat: 41.27976, lon: 36.3361, hasResults: False
protocolSection identificationModule nctId: NCT06369493, orgStudyIdInfo id: OMUKAEK: 2022/210, briefTitle: Examining The Relationship Between Gingival Thickness and Tooth and Gingival Parameters, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-01, primaryCompletionDateStruct date: 2023-12-01, completionDateStruct date: 2023-12-18, studyFirstPostDateStruct date: 2024-04-17, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Ondokuz Mayıs University, class: OTHER, descriptionModule briefSummary: This study aims to assess whether there is a valid correlation between the identified multiple clinical and morphometric parameters and the gingival thickness., conditionsModule conditions: Gingival Thickness, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 50, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Evaluation of the correlation between KGW, CW, CL PH parameters of GT measured in "mm" with a digital caliper with 0.001 mm precision in 1200 teeth in 50 participants using Spearman correlation analysis., primaryOutcomes measure: Evaluation of the effect of GT on keratinized gingival width, measured in "mm" by digital caliper with a precision of 0.001 mm, both by binary logistic regression analysis of 50 participants., primaryOutcomes measure: Examining the effect of age and gender of 50 participants on the gingival thickness measured in mm using binary logistic regression analysis., otherOutcomes measure: Evaluation of researcher reliability by ICC (Intra-Class Correlation Coefficient) in 10 participants in 2 weeks, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ondokuz Mayis University Faculty of Dentistry Department of Periodonthology, city: Samsun, zip: 55200, country: Turkey, geoPoint lat: 41.27976, lon: 36.3361, hasResults: False